Accessibility Menu
Establishment Labs logo

Establishment Labs(NASDAQ) ESTA

Market Cap$2.17BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2018)+194%
5 Year+8%
1 Year+82%
1 Month-23%
Premium Feature
Moneyball Superscore
73/100
$71.97
-0.96%
-0.70Today
After hours$72.09+$0.12 (+0.17%)
Establishment Labs last closing stock price
MetricPriceDate
Last closeUSD 72.672026-08-21
Establishment Labs stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-8.56%USD 79.472026-08-14
1 month-22.58%USD 93.872026-07-22
3 month+0.66%USD 72.192026-05-22
Year to date-0.29%USD 72.882025-12-31
1 year+81.68%USD 40.002025-08-21
3 year+31.01%USD 55.472023-08-22
5 year+8.45%USD 67.012021-08-20
Since inception+193.62%USD 24.752018-07-19

Establishment Labs Financials at a Glance

Market Cap

$2.17BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$245.82M

Net Income (TTM)

-$38.89M

EPS (TTM)

-$1.30

P/E Ratio

-55.86

Dividend

$0.00

Beta (Volatility)

1.67 (High)

Price

$71.97

Volume

258,923.544

Open

$72.81

Previous Close

$72.06

Daily Range

$71.86 - $73.56

52-Week Range

$36.53 - $97.59

Estimated Earnings Date

Nov 4, 2026

ESTA News

SellAlert-Blue.png

A Hedge Fund Dumped Establishment Labs Shares Worth $6.6 Million. Here's a Closer Look at the Transaction.

Robert IzquierdoJul 5, 2026
SellAlert-Red.png

Wealth Manager Sells $7 Million of Establishment Labs After Massive Gains. Is This Medical Device Stock a Buy?

Kris EddyMay 30, 2026
SellAlert-Purple.png

ESTA Founder Sells $7.9M on Earnings Day — Here's Why that's Not the Story

Seena HassounaMay 11, 2026
SellAlert-Green.png

Establishment Labs Insider Sells 37,500 Shares as Stock Jumps 128% in a Year

Jonathan PoncianoApr 21, 2026
Stock chart down - person covering face

Why Establishment Labs Stock Is Crashing Today

Keith SpeightsNov 8, 2023

ESTA: Motley Fool Moneyball Superscore

73

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Establishment Labs

Establishment Labs Holdings Inc. makes tools for plastic surgery. These products help patients with breast reconstruction or aesthetic changes. The company sells silicone-filled implants and tissue expanders.

Beyond the Standard Implant

  • Motiva Implants: Silicone gel-filled breast implants used for aesthetic and reconstructive surgery.
  • Motiva Flora: Tissue expanders used to prepare breast tissue for permanent implants.
  • Puregraft Products: Tools used for harvesting and redistributing a patient's own fat tissue.

Growing the Global Footprint

  • Received FDA approval in September 2024 to sell Motiva Implants in the United States.
  • Entered into an amended credit agreement for up to $300 million in April 2026.
  • Added to the U.S. small-cap Russell 2000 Index in June 2026.
  • Appointed a new Chief Financial Officer in March 2026.

Specialized Technical Features

Establishment Labs sells its products across Europe, Latin America, and the Asia-Pacific region using direct sales and distributors. Its technology platform focuses on gravity-sensitive implant designs intended to improve safety and aesthetic outcomes.

By the Numbers

  • Market capitalization reached $2.6 billion in Q2 2026, up 105.3% year over year.
  • Revenue was $127.4 million for the six-month period ended June 30, 2026, up 37.5% year over year.
  • Net loss narrowed to $25.1 million for the six-month period ended June 30, 2026.
  • Cash and cash equivalents totaled $71.2 million as of June 30, 2026.

Bottom Line

Establishment Labs has evolved from a developing medical technology firm into a commercial-stage enterprise with a presence in the United States. The company continues to focus on global market expansion and new product development for the plastic surgery industry.

AI Generated • Aug 8, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

1,004

CEO

Peter Caldini, MBA

Website

www.establishmentlabs.com

Headquarters

Austin, TX 78758, US

ESTA Financials

Key Financial Metrics (TTM)

Gross Margin

70.49%

Operating Margin

-7.63%

Net Income Margin

-15.82%

Return on Equity

-203.88%

Return on Capital

-13.54%

Return on Assets

-11.05%

Earnings Yield

-1.79%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.17BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

29.80M

Volume

258.92K

Avg. Volume

614.65K

Financials (TTM)

Gross Profit

$173.27M

Operating Income

-$18.76M

EBITDA

-$6.69M

Operating Cash Flow

-$32.72M

Capital Expenditure

-$9.34M

Free Cash Flow

-$42.06M

Cash & ST Invst.

$71.16M

Total Debt

$263.67M

Establishment Labs Performance Analysis

Establishment Labs annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 161,700,00027.6%
20232023-12-31USD 165,151,0002.1%
20242024-12-31USD 166,025,0000.5%
20252025-12-31USD 211,076,00027.1%
Establishment Labs sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-304.8%
Q42025-12-3120.1%
Q12026-03-31-7.3%
Q22026-06-3012.8%
Establishment Labs annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -3.0879.2%
20232023-12-31USD -3.07-0.3%
20242024-12-31USD -3.00-2.0%
20252025-12-31USD -1.72-42.6%
Establishment Labs sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3032.1%
Q42025-12-3176.8%
Q12026-03-31-409.6%
Q22026-06-3013.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$67.54M

+31.7%

Gross Profit

$47.71M

+35.3%

Gross Margin

70.64%

N/A

Market Cap

$2.17BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$2.16M

N/A

Employees

1,004

N/A

Net Income

-$11.75M

+29.2%

EBITDA

$652.00K

+109.3%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$71.16M

+30.2%

Total Debt

$263.67M

+14.1%

Accounts Receivable

$75.65M

+7.9%

Inventory

$84.98M

-10.2%

Long Term Debt

$263.67M

+17.5%

Short Term Debt

$0.00

-100.0%

Return on Assets

-11.05%

N/A

Return on Invested Capital

-6.53%

N/A

Free Cash Flow

-$20.15M

+0.8%

Operating Cash Flow

-$16.60M

+11.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ZYMEZymeworks Inc.
$28.77+0.35%
UFPTUFP Technologies, Inc.
$305.39-1.21%
NVCRNovocure Ltd
$16.76-1.99%
KMTSKestra Medical Technologies, Ltd.
$26.91-0.30%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$208.48-0.03%
BITOProShares Trust - ProShares Bitcoin ETF
$10.63+0.02%
INTCIntel
$87.26-0.03%
IBITiShares Bitcoin Trust
$44.64+0.02%

Questions About ESTA

What is the current price of Establishment Labs?

Establishment Labs is trading at $72.06 per share.

What is the 52-week range for Establishment Labs?

Over the past 52 weeks, Establishment Labs has traded between $36.53 and $97.59.

How much debt does Establishment Labs have?

As of the most recent reporting period, Establishment Labs reported total debt of $263.67M.

How much cash does Establishment Labs have on hand?

Establishment Labs reported $71.16M in cash and cash equivalents in its most recent financial results.

What is Establishment Labs’s dividend yield?

Establishment Labs does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services